STRATA Skin Sciences, Inc. Appoints Douglas S. Strang to Serve as A Member of the Board of Directors
October 28, 2021 at 04:21 pm EDT
Share
On October 27, 2021, based upon the recommendation of the Nominating and Governance Committee, the Board of Directors of Strata Skin Sciences, Inc. (the ?Company?) appointed Douglas S. Strang to serve as a member of the Company?s Board of Directors until the earlier of Mr. Strang?s resignation or his successor has been elected and qualified. Mr. Strang is a Certified Public Accountant in the State of Pennsylvania and holds a BS degree in accounting from Penn State University and an MBA from Villanova University. Mr. Strang was a partner at PwC and retired after more than 35 years of employment with the firm. His most recent position was as the firm?s Global Pharmaceuticals & Life Science Advisory Leader.
STRATA Skin Sciences, Inc. is a medical technology company in dermatology. The Company is engaged in developing, commercializing and marketing products for the treatment of dermatologic conditions. The Company operates through two segments: Dermatology Recurring Procedures and Dermatology Procedures Equipment. The Companyâs products include the XTRAC and Pharos excimer lasers and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its products also include the TheraClear Acne Therapy System utilized in the treatment of mild to moderate inflammatory, comedonal and pustular acne. The XTRAC and Pharos excimer laser technology emits highly concentrated ultraviolet (UV) light targeted primarily towards autoimmune dermatological skin disorders, such as psoriasis, vitiligo, atopic dermatitis, and eczema, among others. VTRAC is a UV light lamp system that works in much the same way as the XTRAC.